| Acute pyelonephritis in pregnancy: a retrospective study. | |
| | |
MedLine Citation:
|
PMID: 17627687 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: To examine the incidence, risk factors, microbial pathogens, and pregnancy outcomes of pregnant women with acute antepartum pyelonephritis. METHODS: Among all pregnant women admitted to Patan Hospital, Nepal from 14 April 2004 to 13 April 2005, pregnant women with acute pyelonephritis were retrospectively studied. Furthermore, the pregnancy outcomes of these women were compared with those of the general obstetric population received at our hospital during the same time period. RESULTS: Of 7034 pregnant women delivered at our hospital, 94 cases of acute antepartum pyelonephritis were diagnosed during the study period (incidence: 1.3%). Maternal mean age for the infection was 22 +/- 3.41 years. Acute pyelonephritis was most frequently occurred in nulliparous women (75%), and in the second trimester (60%). Of 94 cases, 62 (65.95%) showed positive urine culture, with the predominating organism Escherichia coli in 81% (50 of 62) of cases. E. coli was found most sensitive to nitrofurantoin (82.1% of cases), followed by ceftriaxone (81.55% of cases), gentamicin (77.01% of cases), ofloxacin (60.57% of cases), and ciprofloxacin (59% of cases). The incidences of low-birthweight babies (14%) and preterm babies (7.81%) in the cases with acute antepartum pyelonephritis were not significantly different compared to that of all births in our hospital during the same period (13% and 8%, respectively; P > 0.05). CONCLUSIONS: Acute pyelonephritis requiring admission to hospital most frequently occurs in nulliparous women, and in the second trimester. The predominating organism responsible for acute pyelonephritis is E. coli. Ceftriaxone, because of its safety and negligible side-effect, should be the drug of choice for acute antepartum pyelonephritis. |
| | |
Authors:
|
Paban Sharma; Laxmi Thapa |
Related Documents
:
|
21651707 - Unintended pregnancy and taxpayer spending. 15902527 - Giant cell arteritis in a patient with acute aortic insufficiency with thyrotoxicosis. 16122057 - The liver in pregnancy: disease vs benign changes. 11376667 - Acute fatty liver and hellp syndrome: two distinct pregnancy disorders. 21793087 - Aberrant right subclavian artery (arsa). incidence and correlation with other markers o... 19562067 - Assessing tubal damage. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: The Australian & New Zealand journal of obstetrics & gynaecology Volume: 47 ISSN: 0004-8666 ISO Abbreviation: Aust N Z J Obstet Gynaecol Publication Date: 2007 Aug |
Date Detail:
|
Created Date: 2007-07-13 Completed Date: 2007-10-02 Revised Date: 2009-11-11 |
Medline Journal Info:
|
Nlm Unique ID: 0001027 Medline TA: Aust N Z J Obstet Gynaecol Country: Australia |
Other Details:
|
Languages: eng Pagination: 313-5 Citation Subset: IM |
Affiliation:
|
Department of Obstetrics and Gynecology, Patan Hospital, Lalitpur, Nepal. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Acute Disease Adult Anti-Bacterial Agents / therapeutic use Ceftriaxone / therapeutic use Escherichia coli Infections / complications, diagnosis, drug therapy Female Humans Incidence Infant, Low Birth Weight Infant, Newborn Infant, Premature Length of Stay Nepal / epidemiology Parity Pregnancy Pregnancy Complications Pregnancy Complications, Infectious Pregnancy Outcome* Pregnancy Trimester, Second Pyelonephritis / diagnosis, drug therapy, epidemiology*, microbiology Retrospective Studies Risk Factors |
| Chemical | |
Reg. No./Substance:
|
0/Anti-Bacterial Agents; 73384-59-5/Ceftriaxone |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Screening for gestational diabetes: the effect of varying blood glucose definitions in the predictio...
Next Document: A new way of looking at Caesarean section births.